Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytochrome c pseudogene 39 (CYCSP39)
- Target
- CYCSP39
- Molecular classification
- Pseudogene, Processed pseudogene, Non-coding DNA segment
01
Overview
Cytochrome c pseudogene 39 (CYCSP39, also called HC1 or HCP39) is one of 49 cytochrome c pseudogenes identified in the human genome. These pseudogenes originated from retrotransposition events, meaning genetic material from the cytochrome c gene was copied and inserted back into the genome as non-functional copies. Most cytochrome c pseudogenes, including CYCSP39, contain disablements such as frame shifts and premature stop codons, and none are normally expressed as proteins in humans. While some pseudogenes in other families have become key regulators or disease-related, CYCSP39 has no documented biological function, disease association, or therapeutic relevance. Its primary importance is as a component of the molecular record for cytochrome c gene evolution in primates.
- Other names
- HC1HCP39
02
Mechanism of action
None; drug mechanisms do not target pseudogenes directly
03
Biological functions
None known for CYCSP39; typical pseudogene functions may include genomic regulation, evolutionary records, and rare epigenetic effects, but there is no evidence for direct biological role in humans
04
Disease associations
None specific to CYCSP39; generally, most cytochrome c pseudogenes do not have direct implication in disease
05
Safety considerations
None; not applicable for non-functional pseudogenes.
06
Interacting drugs
None; pseudogenes are not drug targets
07
Biomarkers
None; pseudogenes are rarely used as biomarkers, and there is no evidence for CYCSP39
Beyond the preview
Go deeper on Cytochrome c pseudogene 39 (CYCSP39).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cytochrome c pseudogene 39 (CYCSP39).